Training und prospektive Validierung eines deep-learning nnU-NET zur vollautomatischen Segmentierung der [18F]PSMA-1007 PET/CT
Felix Kind, K Brueggemann, C-F Wielenberg, Katharina Eckstein et autres
0 citationsNuklearmedizin - NuclearMedicine
Felix Kind
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
36Publications signalées
292Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
Prostate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsProstate Cancer Diagnosis and TreatmentMedical Imaging Techniques and ApplicationsCancer, Lipids, and Metabolism
Publications récentes
Einzeitpunkt-Dosimetrie während der [¹⁷⁷Lu]Lu-PSMA-617-Therapie unter Verwendung von Machine Learning und populationsbasierter Modellselektion mit nichtlinearen gemischten Effekten
Deni Hardiansyah, T M Zaki Yasykur Polem, Elham Yousefzadeh-Nowshahr, U. Nemer et autres
0 citationsNuklearmedizin - NuclearMedicine
Neue Risikogruppen für Prostatakrebs anhand der PSMA-PET (PPP3)
J Enste, M Karpinski, Caner Civan, I Rauscher et autres
0 citationsNuklearmedizin - NuclearMedicine
New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort study
Madeleine J Karpinski, Caner Civan, Isabel Rauscher, Osman Güven et autres
3 citationsThe Lancet Oncology
Accuracy and precision of few‐time‐points renal dosimetry for [ 177 Lu]Lu‐PSMA‐617 therapy: Analysis with nonlinear mixed‐effects modeling
Assyifa R. Hakim, Deni Hardiansyah, Elham Yousefzadeh‐Nowshahr, U. Nemer et autres
0 citationsMedical Physics
Prognostic value of whole-body tumor SUV dispersion on baseline PSMA PET prior to PSMA radioligand therapy
Felix Kind, U. Nemer, Cordula A. Jilg, Philipp T. Meyer et autres
2 citationsAnnals of Nuclear Medicine
Correlation of PSMA-PET uptake to histopathological grading: Analysis of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
P Waibel, Ievgen Glavynskyi, Tobias Fechter, M. Mix et autres
0 citationsEuropean Urology Open Science
Single‐time‐point tumor dosimetry using population‐based model selection and nonlinear mixed‐effects modeling in [ 177 Lu]Lu‐PSMA‐617 therapy
Deni Hardiansyah, Elham Yousefzadeh‐Nowshahr, Indra Budiansah, U. Nemer et autres
0 citationsMedical Physics
Updated prostate cancer risk groups by PSMA-PET PROMISE (PPP2): Results from an international multi-centre registry study.
Wolfgang P. Fendler, Madeleine J. Karpinski, Sebastian Hoberück, Isabel Rauscher et autres
1 citationJournal of Clinical Oncology
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study
Madeleine J. Karpinski, Kambiz Rahbar, Martin Bögemann, Laya Rahbar Nikoukar et autres
26 citationsEuropean Urology
MP13-03 PROSTATE CANCER RISK GROUPS BY PSMA-PET PROMISE (PPP): RESULTS FROM AN INTERNATIONAL MULTI-CENTER REGISTRY STUDY
Claudia Kesch, Madeleine J. Karpinski, Sebastian Hoberück, Isabel Rauscher et autres
0 citationsThe Journal of Urology
The Ectonucleotidases CD39 and CD73 and the Purinergic Receptor P2X4 Serve as Prognostic Markers in Non-Small Cell Lung Cancer
Konrad Kurowski, Sophie Nicole Prozmann, António Eduardo Cabrita Figueiredo, Jannis Heyer et autres
4 citationsCancers
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.